Clinical Trials

From regulatory shifts to breakthrough diagnostics, the stories that defined clinical labs in 2025

Early transcriptomic readouts reveal pharmacodynamic activity in skin within days—a shift toward earlier molecular decision-making

While most clinical trial processes have gone digital, site-to-lab data capture still lags behind. Here’s why that matters and what’s changing

Learn how structured, centralized clinical data is accelerating evidence-based decisions

North American and African clinical trials led by Scripps Research, IAVI, and additional collaborators across the US and Africa mark progress toward an effective HIV vaccine

Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals, and improved drug safety

As clinical trial sponsors aim to reduce patient burden and improve engagement, point-of-care testing offers practical advantages

OKN4395 is the first compound to be developed using K1.0, Owkin’s AI-powered operating system

Latest version of Trial Accelerator™ incorporates new AI capabilities and product features to unlock a patient-centric approach to trial design and implementation

A third of Phase 2 clinical trials were terminated in 2024, a 50 percent increase from before the pandemic